These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum neurofilament light chain as outcome marker for intensive care unit patients. Fisse AL; Pitarokoili K; Leppert D; Motte J; Pedreiturria X; Kappos L; Gold R; Kuhle J; Yoon MS J Neurol; 2021 Apr; 268(4):1323-1329. PubMed ID: 33098034 [TBL] [Abstract][Full Text] [Related]
4. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity. Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818 [TBL] [Abstract][Full Text] [Related]
5. Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis. Brenner J; Mariotto S; Bastiaansen AEM; Paunovic M; Ferrari S; Alberti D; de Bruijn MAAM; Crijnen YS; Schreurs MWJ; Neuteboom RF; Damoiseaux JGMC; de Vries JM; Titulaer MJ Neurology; 2023 May; 100(21):e2204-e2213. PubMed ID: 37015822 [TBL] [Abstract][Full Text] [Related]
6. Serum neurofilament measurement improves clinical risk scores for outcome prediction after cardiac arrest: results of a prospective study. Hunziker S; Quinto A; Ramin-Wright M; Becker C; Beck K; Vincent A; Tisljar K; Disanto G; Benkert P; Leppert D; Pargger H; Marsch S; Raoul Sutter ; Peters N; Kuhle J Crit Care; 2021 Jan; 25(1):32. PubMed ID: 33472689 [TBL] [Abstract][Full Text] [Related]
7. Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19. Bark L; Larsson IM; Wallin E; Simrén J; Zetterberg H; Lipcsey M; Frithiof R; Rostami E; Hultström M Sci Rep; 2023 Aug; 13(1):13144. PubMed ID: 37573366 [TBL] [Abstract][Full Text] [Related]
8. Blood Biomarkers as Prognostic Indicators for Neurological Injury in COVID-19 Patients: A Systematic Review and Meta-Analysis. Huang Z; Haile K; Gedefaw L; Lau BW; Jin L; Yip SP; Huang CL Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958721 [TBL] [Abstract][Full Text] [Related]
9. Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population-an analysis from the MEMO study. Rübsamen N; Maceski A; Leppert D; Benkert P; Kuhle J; Wiendl H; Peters A; Karch A; Berger K BMC Med; 2021 Feb; 19(1):38. PubMed ID: 33583409 [TBL] [Abstract][Full Text] [Related]
10. Neurofilament light chain in central nervous system infections: a prospective study of diagnostic accuracy. van Zeggeren IE; Ter Horst L; Heijst H; Teunissen CE; van de Beek D; Brouwer MC Sci Rep; 2022 Aug; 12(1):14140. PubMed ID: 35986031 [TBL] [Abstract][Full Text] [Related]
11. Agreement Between Published Reference Resources for Neurofilament Light Chain Levels in People With Multiple Sclerosis. Sotirchos ES; Hu C; Smith MD; Lord HN; DuVal AL; Arrambide G; Montalban X; Akgün K; Ziemssen T; Naismith RT; Hersh CM; Hyland M; Krupp LB; Nicholas JA; Bermel RA; Mowry EM; Calabresi PA; Fitzgerald KC Neurology; 2023 Dec; 101(23):e2448-e2453. PubMed ID: 37816633 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of serum/plasma neurofilament light chain for COVID-19-associated mortality. Masvekar RR; Kosa P; Jin K; Dobbs K; Stack MA; Castagnoli R; Quaresima V; Su HC; Imberti L; Notarangelo LD; Bielekova B Ann Clin Transl Neurol; 2022 May; 9(5):622-632. PubMed ID: 35313387 [TBL] [Abstract][Full Text] [Related]
14. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study. Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M Front Immunol; 2021; 12():719432. PubMed ID: 34975832 [TBL] [Abstract][Full Text] [Related]
15. Serum Neurofilament Light Chain as a Marker of Progression in Parkinson's Disease: Long-Term Observation and Implications of Clinical Subtypes. Ygland Rödström E; Mattsson-Carlgren N; Janelidze S; Hansson O; Puschmann A J Parkinsons Dis; 2022; 12(2):571-584. PubMed ID: 34806619 [TBL] [Abstract][Full Text] [Related]
16. Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1). Nicoletti TF; Rossi S; Vita MG; Perna A; Guerrera G; Lino F; Iacovelli C; Di Natale D; Modoni A; Battistini L; Silvestri G J Neurol; 2022 Sep; 269(9):5085-5092. PubMed ID: 35575811 [TBL] [Abstract][Full Text] [Related]
17. Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity Among Preterm Infants. Sjöbom U; Hellström W; Löfqvist C; Nilsson AK; Holmström G; Pupp IH; Ley D; Blennow K; Zetterberg H; Sävman K; Hellström A JAMA Netw Open; 2021 Apr; 4(4):e214138. PubMed ID: 33797551 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of neurofilament light chain, neuron-specific enolase and S100 calcium-binding protein B during acute bacterial meningitis: a prospective cohort study. Grønhøj MH; Sejbaek T; Hansen RW; Larsen L; Dahl M; Schierbeck J; Poulsen FR Infect Dis (Lond); 2021 Jun; 53(6):409-419. PubMed ID: 33583314 [TBL] [Abstract][Full Text] [Related]
19. The role of neurofilament light chain in COVID‑19: A potential prognostic biomarker. Heidari A; Rezaei N Acta Neurobiol Exp (Wars); 2023; 83(2):111-126. PubMed ID: 37493529 [TBL] [Abstract][Full Text] [Related]
20. Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19. Prudencio M; Erben Y; Marquez CP; Jansen-West KR; Franco-Mesa C; Heckman MG; White LJ; Dunmore JA; Cook CN; Lilley MT; Song Y; Harlow CF; Oskarsson B; Nicholson KA; Wszolek ZK; Hickson LJ; O'Horo JC; Hoyne JB; Gendron TF; Meschia JF; Petrucelli L Sci Transl Med; 2021 Jul; 13(602):. PubMed ID: 34131052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]